Systematic Review of Time Lag Between Antibiotic Use and Rise of Resistant Pathogens Among Hospitalized Adults in Europe

Overview

Journal JAC Antimicrob Resist

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2023 Jan 25

PMID 36694849

Authors

Edith Poku

Katy Cooper

Anna Cantrell

Sue Harnan

Muna Abu Sin

Arina Zanuzdana

Alexandra Hoffmann

Affiliations

Soon will be listed here.

Abstract

Background: Antimicrobial resistance (AMR) causes substantial health and economic burden to individuals, healthcare systems and societies globally. Understanding the temporal relationship between antibiotic consumption and antibiotic resistance in hospitalized patients can better inform antibiotic stewardship activities and the time frame for their evaluation.

Objectives: This systematic review examined the temporal relationship between antibiotic use and development of antibiotic resistance for 42 pre-defined antibiotic and pathogen combinations in hospitalized adults in Europe.

Methods: Searches in MEDLINE, Embase, Cochrane Library and NIHR Centre for Reviews and Dissemination were undertaken from 2000 to August 2021. Pathogens of interest were , , , , , CoNS, and complex.

Results: Twenty-eight ecological studies and one individual-level study were included. Ecological studies were predominantly retrospective in design (19 studies) and of reasonable (20 studies) to high (8 studies) methodological quality. Of the eight pathogens of interest, no relevant data were identified for . and CoNS. Across all pathogens, the time-lag data from the 28 ecological studies showed a similar pattern, with the majority of studies reporting lags ranging from 0 to 6 months.

Conclusions: Development of antibiotic resistance for the investigated antibiotic/pathogen combinations tends to occur over 0 to 6 months following exposure within European hospitals. This information could inform planning of antibiotic stewardship activities in hospital settings.

Citing Articles

Examining pharmacoepidemiology of antibiotic use and resistance in first-line antibiotics: a self-controlled case series study of in small companion animals.

Chan O, Lam W, Naing T, Cheong D, Lee E, Cowling B Front Antibiot. 2025; 3():1321368.

PMID: 39816268 PMC: 11731916. DOI: 10.3389/frabi.2024.1321368.

Predicting future hospital antimicrobial resistance prevalence using machine learning.

Vihta K, Pritchard E, Pouwels K, Hopkins S, Guy R, Henderson K Commun Med (Lond). 2024; 4(1):197.

PMID: 39390045 PMC: 11467333. DOI: 10.1038/s43856-024-00606-8.

Comparison of Different Methods for Assaying the In Vitro Activity of Cefiderocol against Carbapenem-Resistant Strains: Influence of Bacterial Inoculum.

Garcia-Rivera C, Sanchez-Bautista A, Parra-Grande M, Ricart-Silvestre A, Ventero M, Tyshkovska I Antibiotics (Basel). 2024; 13(7).

PMID: 39061345 PMC: 11273683. DOI: 10.3390/antibiotics13070663.

Costs of antibiotic resistance genes depend on host strain and environment and can influence community composition.

Lai H, Cooper T Proc Biol Sci. 2024; 291(2025):20240735.

PMID: 38889784 PMC: 11285728. DOI: 10.1098/rspb.2024.0735.

Effects of a Primary Care Antimicrobial Stewardship Program on Meticillin-Resistant Strains across a Region of Catalunya (Spain) over 5 Years.

Jover-Saenz A, Ramirez-Hidalgo M, Belles Belles A, Murillo E, Batlle Bosch M, Ribe Miro A Antibiotics (Basel). 2024; 13(1).

PMID: 38247651 PMC: 10812605. DOI: 10.3390/antibiotics13010092.

References

Bakhit M, Hoffmann T, Scott A, Beller E, Rathbone J, Del Mar C . Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis. BMC Med. 2018; 16(1):126. PMC: 6091205. DOI: 10.1186/s12916-018-1109-4. View

Ghenea A, Cioboata R, Drocas A, tieranu E, Vasile C, Morosanu A . Prevalence and Antimicrobial Resistance of Strains Isolated from a County Hospital in Romania. Antibiotics (Basel). 2021; 10(7). PMC: 8300768. DOI: 10.3390/antibiotics10070868. View

Aldeyab M, Monnet D, Lopez-Lozano J, Hughes C, Scott M, Kearney M . Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother. 2008; 62(3):593-600. DOI: 10.1093/jac/dkn198. View

Kaier K, Frank U, Hagist C, Conrad A, Meyer E . The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains: a time-series analysis. J Antimicrob Chemother. 2009; 63(3):609-14. DOI: 10.1093/jac/dkn534. View

Dualleh N, Chanchiri I, Skjot-Arkil H, Pedersen A, Rosenvinge F, Johansen I . Colonization with multiresistant bacteria in acute hospital care: the association of prior antibiotic consumption as a risk factor. J Antimicrob Chemother. 2020; 75(12):3675-3681. DOI: 10.1093/jac/dkaa365. View

Vibet M, Roux J, Montassier E, Corvec S, Juvin M, NGohou C . Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis. Eur J Clin Microbiol Infect Dis. 2015; 34(10):1957-63. DOI: 10.1007/s10096-015-2437-3. View

Remschmidt C, Behnke M, Kola A, Pena Diaz L, Rohde A, Gastmeier P . The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study. Antimicrob Resist Infect Control. 2017; 6:95. PMC: 5598045. DOI: 10.1186/s13756-017-0253-5. View

Vernaz N, Huttner B, Muscionico D, Salomon J, Bonnabry P, Lopez-Lozano J . Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother. 2011; 66(4):928-35. DOI: 10.1093/jac/dkq525. View

Bakhit M, Del Mar C, Scott A, Hoffmann T . An analysis of reporting quality of prospective studies examining community antibiotic use and resistance. Trials. 2018; 19(1):656. PMC: 6258384. DOI: 10.1186/s13063-018-3040-6. View

10.

Monnet D, MacKenzie F, Lopez-Lozano J, Beyaert A, Camacho M, Wilson R . Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis. 2004; 10(8):1432-41. PMC: 3320421. DOI: 10.3201/eid1008.020694. View

11.

Costelloe C, Metcalfe C, Lovering A, Mant D, Hay A . Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010; 340:c2096. DOI: 10.1136/bmj.c2096. View

12.

Kaier K, Hagist C, Frank U, Conrad A, Meyer E . Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009; 30(4):346-53. DOI: 10.1086/596605. View

13.

Lopez-Lozano J, Lawes T, Nebot C, Beyaert A, Bertrand X, Hocquet D . A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance. Nat Microbiol. 2019; 4(7):1160-1172. DOI: 10.1038/s41564-019-0410-0. View

14.

Mahamat A, MacKenzie F, Brooker K, Monnet D, Daures J, Gould I . Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimicrob Agents. 2007; 30(2):169-76. DOI: 10.1016/j.ijantimicag.2007.04.005. View

15.

Gharbi M, Moore L, Gilchrist M, Thomas C, Bamford K, Brannigan E . Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit. Int J Antimicrob Agents. 2015; 46(2):150-6. PMC: 4526541. DOI: 10.1016/j.ijantimicag.2015.03.005. View

16.

Ahn J, Song J, Kim M, Choi H, Kim J, Ann H . Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study. Am J Infect Control. 2014; 42(6):621-5. DOI: 10.1016/j.ajic.2014.02.024. View

17.

Masuda N, Ohya S . Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1992; 36(9):1847-51. PMC: 192198. DOI: 10.1128/AAC.36.9.1847. View

18.

Gallini A, Degris E, Desplas M, Bourrel R, Archambaud M, Montastruc J . Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. J Antimicrob Chemother. 2010; 65(12):2650-7. DOI: 10.1093/jac/dkq351. View

19.

Popovic R, Tomic Z, Tomas A, Andelic N, Vickovic S, Jovanovic G . Five-year surveillance and correlation of antibiotic consumption and resistance of Gram-negative bacteria at an intensive care unit in Serbia. J Chemother. 2020; 32(6):294-303. DOI: 10.1080/1120009X.2020.1755588. View

20.

Willmann M, Marschal M, Holzl F, Schroppel K, Autenrieth I, Peter S . Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013; 57(4):1797-803. PMC: 3623362. DOI: 10.1128/AAC.02142-12. View